South Africa is going ahead with clinical trials of the tenofovir microbicide gel that has showed a 39% effectiveness in preventing HIV transmission to in women.

By IPS Correspondents Reprint | | Print |

Jun 17 2011 (IPS) - South Africa is going ahead with clinical trials of the tenofovir microbicide gel that has showed a 39% effectiveness in preventing HIV transmission to in women.

[podcast]http://traffic.libsyn.com/ipsaudio/20110616_tenofovir_dejager.mp3[/podcast]